MultivisionDx

Launching a healthcare spinout company is hard. It gets easier when you have great peers who face the same challenges and are happy to share their experiences. Yesterday MultivisionDx and Solid IO were recognized at the University of Helsinki annual Innovation gala as two 2025 spinouts, both working in cancer diagnostics to make sure patients get the right treatments when they need them the most. Congratulations to fellow female founders Noora Hujala and Heidi Haikala and the whole Solid IO team for their hard work, and thank you Helsinki Innovation Services Ltd for having us. Honored to receive this recognition on behalf of all the MultivisionDx founders: Fabien Bertillot, Sara Wickström, Michael Wittinger and János L..

One year ago today, we filed MultivisionDx as a company in the Finnish trade register as a spinout from University of Helsinki. We had two employees, a hot desk in a co-working space, and three months of runway. One year on, we have four full-time staff and a private office with a view of Meilahti campus, we closed a pre-seed funding round, and we are working on exciting collaborative projects to bring our spatial biomarker technology to clinical use. To celebrate, we had cake and candles 🎂 on-prem with our Helsinki-based team Karolina and János. Not pictured: Michael, Fabien and Sara celebrating from three different countries. 🧁

Interested in discussing how we develop oncology biomarkers from AI-driven discovery to the clinic? From our biomarker discovery platform to assay development, we translate complex tumor biology into clinically actionable diagnostics. Come meet Fabien Bertillot, our Head of Computational Biology, who will be hosting a booth in the Cure Village at the Future4care Demo Day in Paris!

Accessing funding is vital for every health sector startup. But how to find the right investors in such a specialized field? Apply to Health Incubator Helsinki, and we'll support you! 💰 Since 2020, startups in our program have raised more than €65M, including €22.4M secured last year. We offer: 🚀 Access to our extensive investor network 🚀 Assistance and advice in securing funding 🚀 Opportunities to meet investors face-to-face at various events organized by Health Incubator Helsinki and our ecosystem partners …and much more. Interested to join the 7th batch of Health Incubator Helsinki? 👉 Submit your application by 28 February 2026: https://lnkd.in/dS6J8cU #healthinnovation #healthstartups #lifesciences #healthtech #medtech #biotech #digitalhealth #helsinki 

Super proud to announce our investment in MultivisionDx! Antler led MultivisionDX's €1M pre-seed round. We have been impressed by the potential of the diagnostic platform the team has developed and teams ability to share their vision and execute on the plan. The progress after the first discussions has been awesome. Really looking forward to continue to support the team in their journey. Congrats Michael Wittinger, Karolina, János L., Fabien Bertillot and Sara Wickström

Honoured to be among the early investors in MultivisionDx to promote highly personalised treatment for cancer patients and thereby improve the patient outcomes. So proud of the team and their scientific achievements🙏🏻🫶🏻

MultivisionDx secures €1M in pre-seed funding! 🚀     This investment will accelerate the development of our spatial biology platform and transform personalized diagnostics to improve patient outcomes in the clinic. The funding round, led by Antler with significant contributions from Helsinki University Funds, Kaikarhenni and a Finnish angel investor, enables us to: 🔬 Expand and scale our spatial biology platform  🔬 Advance validation with leading cancer centers  🔬 Accelerate our path toward a diagnostic that truly benefits patients Our belief is simple:  The next leap in precision medicine will come from providing an in-depth understanding of the tumor together with its microenvironment - spatially, quantitatively, and at scale. And we are building exactly that. As a team we are proud of this achievement, highly grateful for the trust of our investors, and excited for what’s next. Full story in the comments 👇 

MultivisionDx at Mayo Clinic: Accelerating Our Path Into the U.S. Market 🚀 Karolina Punovuori and Michael Wittinger returned from an inspiring week in Rochester, where MultivisionDx had the opportunity to visit Mayo Clinic as part of Business Finland´s AMPlify2025 Program, a fantastic initiative helping Finnish Health-tech companies accelerate their path into the U.S. market. During our visit, we met with internationally leading oncologists and pathologists to initiate collaborations that will help us further develop and adapt our spatial-biology diagnostic test with the long-term goal of enabling a smooth U.S. market entry. We also joined the Beahrs Surgical Innovation Summit, an energizing gathering where we learned about the latest developments in surgical oncology, digital pathology, and AI-driven diagnostics. 🔗 https://lnkd.in/dxH-haF3 These are exactly the fields where MultivisionDx sits, at the intersection of #cancerbiology, precision surgery, and AI-powered tissue analysis. The insights and connections from this week will strongly push our next phase of development. Thanks to Business Finland for opening this door and Mayo Clinic Business Development for hosting us. Excited what comes next!

Exciting leadership news at MultivisionDx! 🚀     We welcome Michael Wittinger as the company's new CEO! With 15+ years and proven success in scaling life science companies, Michael’s deep expertise in diagnostics, oncology, and regulatory affairs positions him perfectly to lead the company's next phase: bringing the MultivisionDx compound biomarker technology from research lab to the clinic.  Read more about this milestone here:  https://lnkd.in/dw8pxaFc

MultivisionDx has a fresh new look! 🎉 Check out our redesigned website, and stay tuned for some exciting updates coming over the next few weeks: https://multivision.ai/ Big thanks to Tatu Ritanen & Miikka Tikka for their exceptional design and photography work. If you're looking for a branding partner in Helsinki, we can highly recommend!